Publicaciones

Saturno-Hernández P.J., Martínez-Nicolás I., Poblano-Verástegui O., Vértiz-Ramírez J.d.J., Suárez-Ortiz E.C., Magaña-Izquierdo M., Kawa-Karasik S. Implementation of quality indicators Of care in public hospitals in Third level in Mexico. Salud Publica de Mexico. 1 May 2017. 59:227-235. 10.21149/8228

AÑO: 2017; IF: 1.039

28902310

Vera I, Júdez FJ. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective. Rev Esp Enferm Dig. 2017 Nov;109(11):788-794. doi: 10.17235/reed.2017.5078/2017. Review. PubMed PMID: 28747053.

AÑO: 2017; IF: 1.632

28747053

Saturno-Hernández P., Martínez-Nicolás I. Author's reply to the letter to the editor by Sebastián García Saisó on the article "Implementation of quality of care indicators for third-level public hospitals in Mexico". Salud Publica de Mexico. 2017. 59:609-611. 10.21149/8942

AÑO: 2017; IF: 1.039

29451629

Cebrián-Cuenca AM, Núñez E, Núñez-Villota J, Consuegra-Sánchez L. What would be the fate of the association between saxagliptin and heart failure admission in the SAVOR-TIMI 53 trial if appropriate statistical methods should have been applied? Diabetes Res Clin Pract. 2017 Apr;126:320-321. doi: 10.1016/j.diabres.2017.02.029. Epub 2017 Mar 9. PubMed PMID: 28341488.

AÑO: 2017; IF: 2.548

28341488

Mearin F, Ciriza C, Mínguez M, Rey E, Mascort JJ, Peña E, Cañones P, Júdez J; en nombre de la SEPD, la semFYC, la SEMERGEN y la SEMG. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)]. Aten Primaria. 2017 Mar;49(3):177-194. doi: 10.1016/j.aprim.2017.01.003. Epub 2017 Feb 24. Spanish. PubMed PMID: 28238460; PubMed Central PMCID: PMC6875999.

AÑO: 2017; IF: 1.148

28238460